Marker Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Marker Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Marker Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 498 %, a 34.8% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 498 +129 +34.8% Sep 30, 2024
Q2 2024 616 +351 +133% Jun 30, 2024
Q1 2024 656 +446 +212% Mar 31, 2024
Q4 2023 497 +253 +104% Dec 31, 2023
Q3 2023 369 +88.6 +31.6% Sep 30, 2023
Q2 2023 264 -104 -28.2% Jun 30, 2023
Q1 2023 210 -328 -61% Mar 31, 2023
Q4 2022 244 -483 -66.5% Dec 31, 2022
Q3 2022 281 -552 -66.3% Sep 30, 2022
Q2 2022 368 -451 -55.1% Jun 30, 2022
Q1 2022 538 -190 -26.1% Mar 31, 2022
Q4 2021 727 +87.9 +13.7% Dec 31, 2021
Q3 2021 832 -112 -11.8% Sep 30, 2021
Q2 2021 820 -476 -36.7% Jun 30, 2021
Q1 2021 728 -934 -56.2% Mar 31, 2021
Q4 2020 639 -1.2K -65.2% Dec 31, 2020
Q3 2020 944 -906 -49% Sep 30, 2020
Q2 2020 1.3K -115 -8.13% Jun 30, 2020
Q1 2020 1.66K +659 +65.7% Mar 31, 2020
Q4 2019 1.84K +1.22K +199% Dec 31, 2019
Q3 2019 1.85K +1.67K +923% Sep 30, 2019
Q2 2019 1.41K +1.16K +456% Jun 30, 2019
Q1 2019 1K +641 +177% Mar 31, 2019
Q4 2018 614 +188 +44.1% Dec 31, 2018
Q3 2018 181 -272 -60.1% Sep 30, 2018
Q2 2018 254 Jun 30, 2018
Q1 2018 361 Mar 31, 2018
Q4 2017 426 Dec 31, 2017
Q3 2017 452 Sep 30, 2017
Q2 2016 19.3 Jun 30, 2016
Q1 2016 13.3 Mar 31, 2016
Q1 2013 1.83 -3.08 -62.7% Mar 31, 2013
Q4 2012 1.29 Dec 31, 2012
Q3 2012 3.1 Sep 30, 2012
Q2 2012 3.91 Jun 30, 2012
Q1 2012 4.91 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.